Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hajjaji

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annales Pharmaceutiques Francaises|August 14, 2001
[Pharmacological study of Ajuga iva]L Bennaghmouch, N Hajjaji, A Zellou, et al.
Presse Medicale (Paris, France : 1983)|December 23, 2004
[Mycobacterium chelonae myositis]N Hajjaji, B Cattier, P Lanotte, et al.
La Revue De Medecine Interne|August 7, 2002
[Paraneoplastic dermatopolymyositis with mild glomerular lesion nephropathy associated with non-Hodgkin's lymphoma]N Hajjaji, V Lesire, P Leturgie, et al.
Gynecologie, Obstetrique & Fertilite|December 9, 2008
[Is staging bone scan useful in patients with small invasive breast carcinoma?]E Simon, H Marret, I Barillot, et al.
Heliyon|June 13, 2020
Corrosion inhibition of brass 60Cu-40Zn in 3% NaCl solution by 3-amino-1, 2, 4-triazole-5-thiolM Damej, D Chebabe, S Abbout, et al.
British Journal of Cancer|November 19, 2009
Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trialP Bougnoux, N Hajjaji, M N Ferrasson, et al.
Cancer Epidemiology|March 16, 2025
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational studyJ Passildas, M J Paillard, L Uwer, et al.
Cancer Medicine|July 6, 2023
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settingsD Hequet, N Hajjaji, E Charafe-Jauffret, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annales Pharmaceutiques Francaises|August 14, 2001
[Pharmacological study of Ajuga iva]L Bennaghmouch, N Hajjaji, A Zellou, et al.
Presse Medicale (Paris, France : 1983)|December 23, 2004
[Mycobacterium chelonae myositis]N Hajjaji, B Cattier, P Lanotte, et al.
La Revue De Medecine Interne|August 7, 2002
[Paraneoplastic dermatopolymyositis with mild glomerular lesion nephropathy associated with non-Hodgkin's lymphoma]N Hajjaji, V Lesire, P Leturgie, et al.
Gynecologie, Obstetrique & Fertilite|December 9, 2008
[Is staging bone scan useful in patients with small invasive breast carcinoma?]E Simon, H Marret, I Barillot, et al.
Heliyon|June 13, 2020
Corrosion inhibition of brass 60Cu-40Zn in 3% NaCl solution by 3-amino-1, 2, 4-triazole-5-thiolM Damej, D Chebabe, S Abbout, et al.
British Journal of Cancer|November 19, 2009
Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trialP Bougnoux, N Hajjaji, M N Ferrasson, et al.
Cancer Epidemiology|March 16, 2025
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational studyJ Passildas, M J Paillard, L Uwer, et al.
Cancer Medicine|July 6, 2023
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settingsD Hequet, N Hajjaji, E Charafe-Jauffret, et al.
Pageof 1